ATE338553T1 - Antitumorkombination aus 3-amino-1,2,4- benzotriazine 1,4-dioxid/paclitaxel/platin - Google Patents

Antitumorkombination aus 3-amino-1,2,4- benzotriazine 1,4-dioxid/paclitaxel/platin

Info

Publication number: ATE338553T1
Authority: AT; Austria
Prior art keywords: benzotriazine; paclitaxel; dioxide; amino; mammal
Prior art date: 1997-03-07

Application number

AT98906594T

Other languages

English (en)

Inventor

Daniel L Dexter

Paul E Juniewicz

James B Rake

Hoff Daniel D Von

Original Assignee

Sanofi Aventis Us Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-07

Filing date

1998-02-17

Publication date

2006-09-15

1998-02-17 Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE338553T1 publication Critical patent/ATE338553T1/de

Links

BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title abstract 6
229930012538 Paclitaxel Natural products 0.000 title abstract 3
229960001592 paclitaxel Drugs 0.000 title abstract 3
229910052697 platinum Inorganic materials 0.000 title abstract 3
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 3
ORYDPOVDJJZGHQ-UHFFFAOYSA-N tirapazamine Chemical compound C1=CC=CC2=[N+]([O-])C(N)=N[N+]([O-])=C21 ORYDPOVDJJZGHQ-UHFFFAOYSA-N 0.000 title abstract 2
230000000259 anti-tumor effect Effects 0.000 title 1
241000124008 Mammalia Species 0.000 abstract 4
206010028980 Neoplasm Diseases 0.000 abstract 2
230000002195 synergetic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT98906594T 1997-03-07 1998-02-17 Antitumorkombination aus 3-amino-1,2,4- benzotriazine 1,4-dioxid/paclitaxel/platin ATE338553T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US81476997A	1997-03-07	1997-03-07

Publications (1)

Publication Number	Publication Date
ATE338553T1 true ATE338553T1 (de)	2006-09-15

Family

ID=25215967

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98906594T ATE338553T1 (de)	1997-03-07	1998-02-17	Antitumorkombination aus 3-amino-1,2,4- benzotriazine 1,4-dioxid/paclitaxel/platin

Country Status (15)

Country	Link
US (2)	US6063780A (de)
EP (1)	EP1014990B1 (de)
JP (1)	JP2001513110A (de)
AT (1)	ATE338553T1 (de)
AU (1)	AU6178198A (de)
BR (1)	BR9808221A (de)
CA (1)	CA2281807C (de)
DE (1)	DE69835824T2 (de)
DK (1)	DK1014990T3 (de)
ES (1)	ES2268764T3 (de)
HR (1)	HRP980095A2 (de)
NO (1)	NO324974B1 (de)
PT (1)	PT1014990E (de)
WO (1)	WO1998039009A1 (de)
ZA (1)	ZA981609B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1014990B1 (de) *	1997-03-07	2006-09-06	Sanofi-Aventis U.S. LLC	Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin
US6866857B1 (en)	1998-10-14	2005-03-15	Debiopharm S.A.	Oxalipatinum preparation packaging
DE19925211B4 (de) *	1999-06-01	2006-01-12	PBS Pharmaceutical Bulk Substances SA	Kit zur Herstellung einer Formulierung von Paclitaxel
US7070796B1 (en)	1999-08-30	2006-07-04	Debiopharm S.A.	Pharmaceutically stable oxaliplatinum preparation for parenteral administration
RU2252022C2 (ru) *	1999-08-30	2005-05-20	Дебиофарм С.А.	Стабильный фармацевтический препарат оксалиплатины для парентерального введения
WO2002047725A2 (fr)	2000-12-12	2002-06-20	Debiopharm S.A.	Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
US6476068B1 (en)	2001-12-06	2002-11-05	Pharmacia Italia, S.P.A.	Platinum derivative pharmaceutical formulations
AU2003261354A1 (en) *	2002-08-02	2004-02-23	The Regents Of The University Of California	New uses for inhibitors of inosine monophosphate dehydrogenase
AU2003239511A1 (en) *	2003-05-20	2004-12-13	Aronex Pharmaceuticals, Inc.	Combination chemotherapy comprising a liposomal platinum complex
US7989490B2 (en)	2004-06-02	2011-08-02	Cordis Corporation	Injectable formulations of taxanes for cad treatment
US20060275331A1 (en) *	2004-08-31	2006-12-07	Borek Zaludek	Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2006248978A (ja)	2005-03-10	2006-09-21	Mebiopharm Co Ltd	新規なリポソーム製剤
CA2624707A1 (en) *	2005-10-03	2007-04-12	Genetix Pharmaceuticals, Inc.	Method for selectively depleting hypoxic cells
US20070212360A1 (en) *	2006-01-17	2007-09-13	Denko Nicholas C	Modulation of mitochondrial oxygen consumption for therapeutic purposes
US8026017B2 (en)	2007-03-16	2011-09-27	The United States Of America As Represented By The Secretary Of The Army	High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes
CN104043125B (zh)	2008-04-10	2018-01-12	弗吉尼亚州立邦联大学	诱导肿瘤缺氧以治疗癌症
WO2014062856A1 (en)	2012-10-16	2014-04-24	Halozyme, Inc.	Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
EP4201403A1 (de) *	2021-12-21	2023-06-28	Som Innovation Biotech, S.L.	Verbindungen tirapazamin und quazinon zur verwendung bei der behandlung von gm2-gangliosidosen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5399363A (en) *	1991-01-25	1995-03-21	Eastman Kodak Company	Surface modified anticancer nanoparticles
US5484612A (en) *	1993-09-22	1996-01-16	The Board Of Trustees Of The Leland Stanford Junior University	Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
EP1014990B1 (de) *	1997-03-07	2006-09-06	Sanofi-Aventis U.S. LLC	Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin

1998
- 1998-02-17 EP EP98906594A patent/EP1014990B1/de not_active Expired - Lifetime
- 1998-02-17 ES ES98906594T patent/ES2268764T3/es not_active Expired - Lifetime
- 1998-02-17 DK DK98906594T patent/DK1014990T3/da active
- 1998-02-17 AU AU61781/98A patent/AU6178198A/en not_active Abandoned
- 1998-02-17 AT AT98906594T patent/ATE338553T1/de not_active IP Right Cessation
- 1998-02-17 PT PT98906594T patent/PT1014990E/pt unknown
- 1998-02-17 JP JP53855198A patent/JP2001513110A/ja not_active Ceased
- 1998-02-17 BR BR9808221-3A patent/BR9808221A/pt not_active Application Discontinuation
- 1998-02-17 DE DE69835824T patent/DE69835824T2/de not_active Expired - Fee Related
- 1998-02-17 WO PCT/US1998/003292 patent/WO1998039009A1/en not_active Ceased
- 1998-02-17 CA CA002281807A patent/CA2281807C/en not_active Expired - Fee Related
- 1998-02-25 HR HR08/814,769A patent/HRP980095A2/hr not_active Application Discontinuation
- 1998-02-26 ZA ZA981609A patent/ZA981609B/xx unknown
- 1998-02-27 US US09/031,692 patent/US6063780A/en not_active Expired - Fee Related
1999
- 1999-09-06 NO NO19994330A patent/NO324974B1/no unknown
2000
- 2000-02-16 US US09/505,043 patent/US6319923B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HRP980095A2 (en)	1998-12-31
EP1014990A1 (de)	2000-07-05
WO1998039009A1 (en)	1998-09-11
EP1014990A4 (de)	2004-03-24
NO994330D0 (no)	1999-09-06
CA2281807C (en)	2007-10-16
JP2001513110A (ja)	2001-08-28
BR9808221A (pt)	2000-05-16
EP1014990B1 (de)	2006-09-06
US6319923B1 (en)	2001-11-20
ZA981609B (en)	1998-12-08
US6063780A (en)	2000-05-16
DE69835824T2 (de)	2007-03-29
DK1014990T3 (da)	2006-12-11
NO994330L (no)	1999-10-25
PT1014990E (pt)	2006-11-30
CA2281807A1 (en)	1998-09-11
DE69835824D1 (de)	2006-10-19
NO324974B1 (no)	2008-01-14
ES2268764T3 (es)	2007-03-16
AU6178198A (en)	1998-09-22

Similar Documents

Publication	Publication Date	Title
DE69835824D1 (de)	2006-10-19	Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin
DK1068870T3 (da)	2006-10-02	Antitumormidler
TR200002243T2 (tr)	2000-12-21	Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı.
DE59709437D1 (de)	2003-04-10	Neue phenanthridine
ATE386808T1 (de)	2008-03-15	Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
MY124091A (en)	2006-06-30	Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
BR9709942A (pt)	1999-08-10	Uso de um composto composição farmacêutica embalagem e processo de tratamento de organismo de animal humano ou não humano para combater ou prevenircondições associadas com a presença de radicais livres no organismo
FI972086A7 (fi)	1997-05-15	Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
MXPA03008623A (es)	2004-05-21	Combinacion farmaceutica para el tratamiento del cancer.
EA200200616A1 (ru)	2002-10-31	Химические производные и их применение в качестве антителомеразного агента
ATE198046T1 (de)	2000-12-15	Neue hemmer von uridinphosphorylase (urdpase) und dihydrouracildehydrogenase (dhudase)
MX9400434A (es)	1994-07-29	Potenciamiento de temozolomida en celulas de tumores humanos.
ATE232394T1 (de)	2003-02-15	Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
MXPA03011270A (es)	2004-03-18	Uso de antagonistas rank para tratar cancer.
ATE243522T1 (de)	2003-07-15	Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren
ATE199641T1 (de)	2001-03-15	Terpenderivate (sarcodictyine) als antikrebsmittel
WO1999011256A8 (en)	1999-08-05	L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
ATE317263T1 (de)	2006-02-15	Diphosphonat derivate von therapeutisch wirksamen stoffen
ATE204476T1 (de)	2001-09-15	Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
DE69426986D1 (de)	2001-05-03	Behandlung von laminitis
RU94024337A (ru)	1996-05-10	Антиметастатическое средство
EA200300222A1 (ru)	2003-08-28	Лечение гепатита c с помощью тимозина, интерферона и рибавирина

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1014990

Country of ref document: EP

2008-11-15

REN

Ceased due to non-payment of the annual fee